adenosine has been researched along with Chronic Disease in 97 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (11.34) | 18.7374 |
| 1990's | 19 (19.59) | 18.2507 |
| 2000's | 34 (35.05) | 29.6817 |
| 2010's | 28 (28.87) | 24.3611 |
| 2020's | 5 (5.15) | 2.80 |
| Authors | Studies |
|---|---|
| Boonyasirinant, T; Kaolawanich, Y; Songsangjinda, T; Thongsongsang, R | 1 |
| Baine, S; Bonilla, IM; Carnes, CA; Fedorov, VV; Glynn, P; Györke, S; Hund, TJ; Kumar, S; Lee, NY; Long, VP; Mohler, PJ; Mowrey, K; Schober, K; Weiss, R | 1 |
| Fukami, Y; Fukuoka, R; Hirai, K; Kajiyama, K; Kawasaki, T; Koga, H; Okonogi, T; Orita, Y; Soejima, T; Umeji, K; Yamabe, H | 1 |
| Chen, X; Li, J; Liu, H; Liu, R; Mao, M; Peng, C; Wu, Y; Yan, S; Yuan, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Bae, MH; Chae, SC; Cho, Y; Jang, SY; Kim, CY; Kim, N; Lee, JH; Park, HS; Yang, DH | 1 |
| Davis, L; Jonker, SS; Louey, S; Musso, J; Nelson, JW; Soman, D | 1 |
| Bi, W; Blackburn, MR; Bollyky, PL; Bruckner, BA; Collum, SD; Hanmandlu, A; Karmouty-Quintana, H; Mertens, TCJ; Molina, JG; Pedroza, M; Philip, KM; Rajadas, J; Ren, D; Sun, W; Thandavarayan, RA; Wareing, N; Wei, W; Wilson, C; Xia, Y | 1 |
| Blackburn, MR; Colgan, SP; Dai, Y; Eltzschig, HK; Glover, L; Grenz, A; Kellems, RE; Luo, R; Ning, C; Sun, H; Sun, K; Tao, L; Wang, W; Xia, Y; Zhang, W; Zhang, Y | 1 |
| Fukushima, Y; Hakozaki, K; Hashimoto, H; Ishihara, K; Kiriyama, T; Kobayashi, Y; Kumita, S; Sakurai, M; Shimizu, W; Suda, M; Takahashi, N; Takano, H; Tomiyama, T | 1 |
| Altenhofen, S; Bogo, MR; Bonan, CD; Cognato, GP; Kist, LW; Leite, CE; Zimmermann, FF | 1 |
| Jacobson, KA; Padia, J; Salvemini, D; Tosh, DK | 1 |
| Apetrei, C; Brocca-Cofano, E; Gillespie, DG; He, T; Jackson, EK; Ma, D; Macatangay, BJ; Pandrea, I; Policicchio, BB; Raehtz, KD; Rinaldo, CR; Stock, JL; Xu, C | 1 |
| Liu, H; Xia, Y | 1 |
| Kawaji, K; Kramer, CM; Lang, RM; Mor-Avi, V; Nathan, S; Patel, AR; Patel, MB | 1 |
| Chen, XM; Fang, X; Huang, XL; Tan, JX; Tao, MJ | 1 |
| By, Y; Condo, J; Deharo, JC; Franceschi, F; Giorgi, R; Guieu, R; Ibrahim, Z; Monserrat, C; Saadjian, A | 1 |
| Blackburn, MR; Schneider, DJ; Zhou, Y | 1 |
| Biaggioni, I; Blackburn, MR; Feoktistov, I; Goldstein, AE; Goleniewska, K; Mitchell, D; Morschl, E; Newcomb, DC; Novitskiy, SV; Peebles, RS; Polosukhin, VV; Ryzhov, S; Yin, H; Zaynagetdinov, R; Zhou, Y | 1 |
| Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ | 1 |
| Dilsizian, V | 1 |
| Cau, J; Favreau, F; Hauet, T; Lerman, LO; Manguy, E; Mauco, G; Milin, S; Thuillier, R; Zhu, X | 1 |
| Di Pietro, N; Pandolfi, A | 1 |
| Davies, RA; Haddad, H; Mielniczuk, L; Reinglas, J | 1 |
| Alvarado, A; Alvarado-Tapias, E; Bello, M; Bonfante-Cabarcas, R; Briceño, M; Rivas-Coppola, M; Rodríguez-Bonfante, C | 1 |
| Montalescot, G; Silvain, J | 1 |
| Aylward, P; Buck, KK; Budaj, A; Cannon, CP; Cornel, JH; Harrington, RA; Horrow, J; James, S; Katus, H; Keltai, M; Lewis, BS; Parikh, K; Storey, RF; Szummer, K; Wallentin, L; Wojdyla, D | 1 |
| Akhondzadeh, S; Boroumand, MA; Ghaleiha, A; Honarbakhsh, N; Jafarinia, M; Raznahan, M; Rezaei, F; Tabrizi, M | 1 |
| Enmi, J; Fukuda, H; Hirano, Y; Iida, H; Knuuti, J; Koshino, K; Miyagawa, S; Sawa, Y; Teramoto, N; Yokoyama, I; Zeniya, T | 1 |
| Alexis, NE; Esther, CR; Picher, M | 1 |
| Buller, CE; Fung, A; Hoole, SP; Mayo, J; Nicolaou, S; Poulter, RS; Seddon, MD | 1 |
| Bhatia, V; Dean, P; Hage, FG; Heo, J; Iqbal, F; Iskandrian, AE | 1 |
| Basra, SS; Lakkis, NM; Tsai, P | 1 |
| Hatakenaka, M; Higuchi, K; Honda, H; Kamitani, T; Matsuo, Y; Mochizuki, T; Nagao, M; Nagashima, M; Shikata, F | 1 |
| Coulden, RA; Grundy, BJ; Khoo, JP; McCann, GP; Sonnex, EP; Steadman, CD | 1 |
| Bianco, MR; Cavaliere, C; Cirillo, G; Marcello, L; Merizzi, G; Papa, M; Petrosino, V; Soleti, A | 1 |
| Mamedova, SI; Petrenko, IV; Petrenko, OA; Popova, MA; Urvantseva, IA | 1 |
| Blackburn, MR; Karmouty-Quintana, H; Xia, Y | 1 |
| Figulla, HR; Werner, GS | 1 |
| Boisseau, MR | 1 |
| Ferrari, M; Figulla, HR; Heinke, S; Kuethe, F; Richartz, BM; Surber, R; Werner, GS | 1 |
| De Man, JG; De Winter, BY; Herman, AG; Pelckmans, PA; Seerden, TC; Van Marck, EA | 1 |
| CARLSON, RG; TALLEY, RW | 1 |
| Battastini, AM; Bonan, CD; Crema, L; da Silva Torres, IL; Dalmaz, C; De Leon Nunes, M; Ferreira, MB; Sarkis, JJ | 1 |
| Inoue, K; Koizumi, S; Tsuda, M | 1 |
| Blom, HJ; De Vriese, AS; Heil, SG; Kluijtmans, LA; Lameire, NH; Mortier, S; Van de Voorde, J | 1 |
| Beck, R; Bentur, L; Berger, I; Berkowitz, D; Elias, N; Gavriely, N; Hasanin, J | 1 |
| Cho, IH; Chun, KA | 1 |
| Fukuda, K; Fukunaga, A; Hayashida, M | 1 |
| Blackburn, MR; Chunn, JL; Kellems, RE; Mi, T; Molina, JG; Xia, Y | 1 |
| Baghdoyan, HA | 1 |
| Borzi, M; Chiricolo, G; Pizzuto, F; Puddu, PE; Romeo, F; Voci, P | 1 |
| Ferrari, M; Figulla, HR; Fritzenwanger, M; Surber, R; Werner, GS | 1 |
| Akundi, RS; Back, SA; Craig, A; Luo, NL; Ren, J; Ribeiro, I; Rivkees, SA | 1 |
| Fujita, M; Hisatome, I; Igawa, O; Kato, M; Kinugawa, T; Kitakaze, M; Ogino, K; Osaki, S; Shigemasa, C | 1 |
| Matera, MG; Polosa, R | 1 |
| Atienza, F; Jalife, J | 1 |
| Chintala, S; Gobe, GG; Goligorsky, MS; Patschan, D; Patschan, S | 1 |
| Hisatome, I | 1 |
| Asakura, M; Asanuma, H; Fujita, M; Furukawa, H; Isomura, T; Kim, J; Kitakaze, M; Komamura, K; Liao, Y; Nakamaru, K; Tomoike, H | 1 |
| Chevrel, B | 1 |
| Martin, JG | 1 |
| Ahlberg, AW; Barbour, MM; Cloutier, DJ; Garber, CE; Heller, GV; McClellan, JR | 1 |
| Hattori, Y; Hayashi, Y; Hori, Y; Islam, N; Moriwaki, A | 1 |
| Bauer, AJ | 1 |
| Kamen, BA; Quinn, CT | 1 |
| Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Minamino, T; Node, K | 1 |
| Sollevi, A | 1 |
| Bauman, RP; Greenfield, JC; Rembert, JC | 1 |
| Baroni, M; Biagini, A; Boni, A; Cortigiani, L; Nannini, E; Palmieri, C; Picano, E; Ravani, M | 1 |
| Canetti, M; Cohen, G; Elkayam, U; Karaalp, IS; Mehra, A; Tummala, PP; Wani, OR | 1 |
| Marshall, JM | 2 |
| Kurumaji, A; Toru, M | 1 |
| Funaya, H; Hori, M; Kitakaze, M; Komamura, K; Koretsune, Y; Kuzuya, T; Minamino, T; Node, K | 1 |
| Hao, JX; Sollevi, A; von Heijne, M; Wiesenfeld-Hallin, Z; Xu, XJ; Yu, W | 1 |
| Kurnaz, F; Sarioğlu, Y; Utkan, NZ; Utkan, T; Yildirim, S | 1 |
| Arnér, S; Belfrage, M; Segerdahl, M; Sollevi, A | 1 |
| Aranda, M; Bradford, KK; Pearl, RG | 1 |
| Kaznowska, Z; Simmonds, HA; Smoleńska, Z; Smoleński, RT; Zarówny, D | 1 |
| Ishikawa, Y; Kimoto, S; Kume, M; Nakayama, H; Ozaki, N; Shimahara, Y; Yamagami, K; Yamamoto, H; Yamamoto, Y; Yamaoka, Y | 1 |
| Hashimoto, K; Inoue, K; Lurie, KG; Shirai, T; Sugiyama, A | 1 |
| Heaps, CL; Laughlin, MH; Parker, JL; Rapps, JA; Sturek, M | 1 |
| Frisbee, JC; Greene, AS; Hudetz, AG; Lombard, JH; Roman, RJ; Tonellato, PJ | 1 |
| Hori, M; Kitakaze, M | 1 |
| Futterman, LG; Lemberg, L | 1 |
| Barron, HV; Botvinick, EH; Lenihan, K; Michaels, AD; Sciammarella, MG | 1 |
| Anderlini, P; Andersson, BS; Andreeff, M; Braunschweig, I; Bruton, J; Champlin, R; Claxton, D; Cohen, A; Davis, M; Donato, M; Gajewski, J; Giralt, S; Ippolitti, C; Khouri, I; Kornblau, S; Molldrem, J; Przepiorka, D; Thall, PF; Ueno, NT; Wang, X | 1 |
| Gascho, JA; Kerber, RE; Marcus, ML; Mueller, TM | 1 |
| Barer, GR; Cai, YN; Emery, CJ; Russell, PC | 1 |
| Bittera, I; Gyurkovits, K; Papp, A; Rápó, J | 1 |
| Kuz'ko, NV | 1 |
| Abboud, FM; Armstrong, ML; Heistad, DD; Marcus, ML | 1 |
| Nilius, R; Zipprich, B | 1 |
| Busse, HJ; Eismann, R; Nilius, R; Otto, L; Peters, JE; Zipprich, B | 1 |
| Gasbarrini, G; Labò, G; Miglio, F | 1 |
| Freyland, M; Frotscher, U; Messerschmidt, W; Richter, R; Schulte-Lippern, M; Wilbrandt, R; Zschaege, B | 1 |
18 review(s) available for adenosine and Chronic Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Beneficial and detrimental role of adenosine signaling in diseases and therapy.
Topics: Adenosine; Animals; Cerebrovascular Disorders; Chronic Disease; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Respiration Disorders; Signal Transduction | 2015 |
Adenosine signaling and the regulation of chronic lung disease.
Topics: Acute Disease; Adenosine; Adenosine Deaminase; Animals; Chronic Disease; Disease Models, Animal; Humans; Lung Diseases, Interstitial; Lung Diseases, Obstructive; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction | 2009 |
Cardiorenal syndrome and heart failure.
Topics: Adenosine; Anemia; Chronic Disease; Diuretics; Heart Failure; Hemofiltration; Humans; Kidney Failure, Chronic; Prognosis; Renin-Angiotensin System; Risk Factors; Vasodilator Agents; Vasopressins | 2010 |
Regulation of airway nucleotides in chronic lung diseases.
Topics: Adenosine; Adenosine Triphosphate; Animals; Chronic Disease; Epithelial Cells; Humans; Lung Diseases; Nucleotides; Respiratory Mucosa | 2011 |
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia | 2011 |
Adenosine signaling during acute and chronic disease states.
Topics: Acute Disease; Adenosine; Animals; Chronic Disease; Humans; Signal Transduction | 2013 |
Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency.
Topics: Adenosine; Animals; Cell Hypoxia; Chronic Disease; Humans; Leg; Lymphatic System; Plant Extracts; Venous Insufficiency | 2002 |
ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4.
Topics: Adenosine; Adenosine Triphosphate; Animals; Central Nervous System; Chronic Disease; Humans; Microglia; Pain; Receptors, Purinergic P2; Receptors, Purinergic P2X4; Signal Transduction | 2004 |
Clinical application of adenosine and ATP for pain control.
Topics: Acute Disease; Adenosine; Adenosine Triphosphate; Animals; Chronic Disease; Humans; Injections, Intravenous; Injections, Spinal; Pain; Pain, Postoperative | 2005 |
[Animal models of bronchial hyperreactivity].
Topics: Adenosine; Animals; Asthma; Bradykinin; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chronic Disease; Cytokines; Dextrans; Disease Models, Animal; Dogs; Guinea Pigs; Inflammation; Leukotrienes; Lipoxygenase; Mast Cells; Ozone; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Tachykinins | 1994 |
Transplantation-induced injuries of the intestinal muscularis and its innervation: from preservation to chronic rejection.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Chronic Disease; Glutathione; Graft Rejection; Humans; Insulin; Intestine, Small; Organ Preservation; Organ Preservation Solutions; Raffinose; Reperfusion Injury; Transplantation, Homologous | 1996 |
A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities.
Topics: Acute Disease; Adenosine; Biopterins; Chronic Disease; Folic Acid Antagonists; Homocysteine; Humans; Methotrexate; Nervous System Diseases; Nucleic Acid Synthesis Inhibitors | 1996 |
Adenosine for pain control.
Topics: Acute Disease; Adenosine; Analgesics; Analgesics, Opioid; Animals; Central Nervous System; Chronic Disease; Disease Models, Animal; Hot Temperature; Humans; Infusions, Intravenous; Injections, Intravenous; Injections, Spinal; Neurons, Afferent; Nociceptors; Pain; Peripheral Nerves; Pressure; Receptors, Cell Surface; Rodentia; Spinal Cord; Touch | 1997 |
Chemoreceptors and cardiovascular control in acute and chronic systemic hypoxia.
Topics: Acute Disease; Adenosine; Cardiovascular Physiological Phenomena; Chemoreceptor Cells; Chronic Disease; Humans; Hypoxia; Muscle, Skeletal; Norepinephrine; Oxygen; Vasoconstriction; Vasodilation | 1998 |
Adenosine therapy: a new approach to chronic heart failure.
Topics: Adenosine; Animals; Cardiac Output, Low; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1 | 2000 |
Roles of adenosine and nitric oxide in skeletal muscle in acute and chronic hypoxia.
Topics: Acute Disease; Adenosine; Animals; Chronic Disease; Humans; Hypoxia; Muscle, Skeletal; Nitric Oxide | 2001 |
Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Cardiomegaly; Chronic Disease; Coronary Circulation; Dogs; Exercise Test; Heart Block; Heart Rate; Humans; Hypertension; Myocardium; Regional Blood Flow; Swine; Vascular Resistance; Vasodilation | 1979 |
10 trial(s) available for adenosine and Chronic Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Cardiovascular Diseases; Chronic Disease; Clopidogrel; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial.
Topics: Adenosine; Adenosine Deaminase; Adult; Chronic Disease; Clozapine; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
Direct assessment of coronary steal and associated changes of collateral hemodynamics in chronic total coronary occlusions.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Echocardiography, Doppler; Female; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Models, Cardiovascular; Radionuclide Angiography; Vascular Resistance; Vasodilator Agents | 2002 |
Effects of intravenous theophylline on exercise-induced myocardial ischemia: II. A concentration-dependent phenomenon.
Topics: Adenosine; Aged; Blood Pressure; Cardiac Complexes, Premature; Chronic Disease; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Rest; Systole; Theophylline; Time Factors | 1993 |
Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure.
Topics: Adenosine; Adult; Aged; Cardiac Output, Low; Chronic Disease; Dilazep; Dipyridamole; Humans; Middle Aged; Prognosis; Vasodilator Agents | 1998 |
The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain.
Topics: Adenosine; Adult; Chronic Disease; Female; Humans; Injections, Spinal; Male; Middle Aged; Pain | 1999 |
Effect of methotrexate on blood purine and pyrimidine levels in patients with rheumatoid arthritis.
Topics: Adenosine; Adenosine Triphosphate; Adult; Aminoimidazole Carboxamide; Antirheumatic Agents; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Chronic Disease; Cytidine Triphosphate; Erythrocytes; Female; Guanosine Triphosphate; Humans; Hypoxanthine; Methotrexate; Middle Aged; Ribonucleotides; Uric Acid; Uridine | 1999 |
Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris.
Topics: Adenosine; Angina Pectoris; Anticoagulants; Blood Pressure; Chronic Disease; Collateral Circulation; Drug Therapy, Combination; Exercise Test; Female; Heart Rate; Heparin; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Ischemia; Neovascularization, Physiologic; Pilot Projects; Severity of Illness Index; Single-Blind Method; Systole; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2000 |
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Topics: Acute Disease; Adenosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
70 other study(ies) available for adenosine and Chronic Disease
| Article | Year |
|---|---|
Clinical values of resting electrocardiography in patients with known or suspected chronic coronary artery disease: a stress perfusion cardiac MRI study.
Topics: Adenosine; Aged; Chronic Disease; Coronary Artery Disease; Electrocardiography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Vasodilator Agents | 2021 |
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Bee Venoms; Biological Clocks; Chronic Disease; Dogs; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart Failure; Heart Rate; In Vitro Techniques; Male; Patch-Clamp Techniques; Potassium Channel Blockers; Receptor, Adenosine A1; Sinoatrial Node; Xanthines | 2020 |
Clinical impact of successful recanalization for chronic total occlusion: insights from stress myocardial perfusion imaging.
Topics: Adenosine; Aged; Chronic Disease; Coronary Circulation; Coronary Occlusion; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Predictive Value of Tests; Recovery of Function; Recurrence; Registries; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vascular Patency; Vasodilator Agents; Ventricular Function, Left | 2020 |
Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria.
Topics: Adenosine; Chronic Disease; Chronic Urticaria; Humans; Omalizumab; Urticaria | 2021 |
Coronary Collaterals Function and Clinical Outcome Between Patients With Acute and Chronic Total Occlusion.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Cardiac Catheterization; Chronic Disease; Collateral Circulation; Coronary Occlusion; Coronary Vessels; Disease-Free Survival; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Factors; Time Factors; Treatment Outcome; Vasodilator Agents | 2017 |
Role of adenosine signaling in coordinating cardiomyocyte function and coronary vascular growth in chronic fetal anemia.
Topics: 5'-Nucleotidase; Adenosine; Anemia; Animals; Antigens, CD; Apyrase; Calcium Signaling; Chronic Disease; Coronary Vessels; Disease Models, Animal; Equilibrative Nucleoside Transport Proteins; Female; Fetal Diseases; Gene Expression Regulation, Developmental; Myocytes, Cardiac; Neovascularization, Physiologic; Pregnancy; Receptors, Purinergic P1; Sheep, Domestic | 2018 |
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine Deaminase; Animals; Cell Line; Chronic Disease; Disease Models, Animal; Extracellular Matrix; Humans; Hyaluronan Synthases; Hyaluronic Acid; Idiopathic Pulmonary Fibrosis; Lung Injury; Macrophages; Mice; Pulmonary Emphysema; Receptor, Adenosine A2B | 2019 |
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension.
Topics: 5'-Nucleotidase; Adenosine; Adult; Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Endothelial Cells; Endothelin-1; Female; Gene Expression; GPI-Linked Proteins; Humans; Hypertension, Renal; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Receptor, Adenosine A2B; Signal Transduction; Vasoconstrictor Agents | 2013 |
Patients with reduced heart rate response to adenosine infusion have low myocardial flow reserve in (13)N-ammonia PET studies.
Topics: Adenosine; Aged; Ammonia; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Perfusion Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2015 |
Unpredictable Chronic Stress Alters Adenosine Metabolism in Zebrafish Brain.
Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Brain; Chronic Disease; Enzyme Assays; Extracellular Space; Gene Expression Regulation; Hydrolysis; Male; Stress, Psychological; Zebrafish | 2016 |
Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Biological Transport, Active; Blood Proteins; Caco-2 Cells; Chronic Disease; Constriction, Pathologic; Half-Life; Humans; In Vitro Techniques; Male; Microsomes, Liver; Mutagenicity Tests; Neuralgia; Protein Binding; Rats; Rats, Sprague-Dawley | 2015 |
Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; Chlorocebus aethiops; Chronic Disease; Cytokines; Dipeptidyl Peptidase 4; Humans; Macaca nemestrina; Male; Receptors, Antigen, T-Cell; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes | 2015 |
Role of Perfusion at Rest in the Diagnosis of Myocardial Infarction Using Vasodilator Stress Cardiovascular Magnetic Resonance.
Topics: Adenosine; Aged; Chronic Disease; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Purines; Pyrazoles; Rest; Retrospective Studies; Vasodilator Agents | 2016 |
[Effects of continuous adenosine infusion on pulmonary hypertension in chronically hypoxic rats].
Topics: Adenosine; Animals; Chronic Disease; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Infusions, Subcutaneous; Male; Nitric Oxide Synthase Type II; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2008 |
Peripheral plasma adenosine release in patients with chronic heart failure.
Topics: Adenosine; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Coronary Sinus; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Serum Albumin; Troponin I | 2009 |
Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice.
Topics: Adenosine; Allergens; Animals; Bronchi; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Models, Animal; Eosinophils; Gene Deletion; Gene Expression Regulation; Hypertrophy; Interleukin-4; Metaplasia; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucus; Myocytes, Smooth Muscle; Pneumonia; Receptor, Adenosine A2B; RNA, Messenger; Transforming Growth Factor beta | 2010 |
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Connectivity of radiotracers to vasodilators is thallium the missing link?
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.
Topics: Adenosine; Allopurinol; Animals; Anticoagulants; Azetidines; Base Sequence; Benzylamines; Chronic Disease; DNA Primers; Fibrosis; Glutathione; Humans; Insulin; Kidney; Kidney Transplantation; Male; Models, Animal; Organ Preservation; Organ Preservation Solutions; Oxidative Stress; Plasminogen Activator Inhibitor 1; Raffinose; RNA, Messenger; Signal Transduction; Swine; Temperature; Tissue Donors; Tissue Plasminogen Activator; Transforming Growth Factor beta; Transplantation, Autologous | 2010 |
High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia?
Topics: Adenosine; Animals; Blood Glucose; Cardiovascular Diseases; Chronic Disease; Humans; Hyperglycemia; Nitric Oxide; Risk Factors | 2010 |
[Adenosine induces ventricular arrythmias in hearts with chronic chagas cardiomyopathy].
Topics: Adenosine; Animals; Arrhythmias, Cardiac; Chagas Cardiomyopathy; Chronic Disease; Heart Ventricles; Rats; Rats, Sprague-Dawley | 2010 |
Ticagrelor in the renal dysfunction subgroup: subjugated or substantiated?
Topics: Acute Coronary Syndrome; Adenosine; Cardiovascular Diseases; Chronic Disease; Hemorrhage; Humans; Kidney Diseases; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticagrelor | 2010 |
Experimental pig model of old myocardial infarction with long survival leading to chronic left ventricular dysfunction and remodeling as evaluated by PET.
Topics: Adenosine; Animals; Chronic Disease; Coronary Vessels; Disease Models, Animal; Male; Myocardial Infarction; Positron-Emission Tomography; Survival Rate; Swine; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Comprehensive assessment of a chronic total occlusion by dual-energy cardiac CT angiography with adenosine stress prior to retrograde percutaneous recanalization.
Topics: Adenosine; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Angiography; Coronary Occlusion; Humans; Male; Middle Aged; Predictive Value of Tests; Tomography, Spiral Computed; Vasodilator Agents | 2011 |
The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
Topics: Adenosine; Alaska; Anti-Arrhythmia Agents; Chronic Disease; Coronary Disease; Diabetes Mellitus; Disease Progression; Female; Follow-Up Studies; Heart Rate; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors | 2011 |
Subendocardial contractile impairment in chronic ischemic myocardium: assessment by strain analysis of 3T tagged CMR.
Topics: Adenosine; Aged; Area Under Curve; Biomechanical Phenomena; Case-Control Studies; Chronic Disease; Coronary Angiography; Endocardium; Female; Humans; Image Processing, Computer-Assisted; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Pericardium; Predictive Value of Tests; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2012 |
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Bundle-Branch Block; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Chronic Disease; Contrast Media; Coronary Stenosis; Cysts; Dobutamine; Exercise Test; Gadolinium DTPA; Heart Neoplasms; Heart Valve Diseases; Humans; Incidental Findings; Lipoma; Liver Diseases; Magnetic Resonance Angiography; Middle Aged; Multiple Pulmonary Nodules; Referral and Consultation; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thrombosis; Vasodilator Agents; Ventricular Dysfunction, Left | 2012 |
Neuropathic pain and reactive gliosis are reversed by dialdehydic compound in neuropathic pain rat models.
Topics: Adenosine; Adenosine Triphosphate; Affinity Labels; Aldehydes; Analgesics; Animals; Astrocytes; Chronic Disease; Disease Models, Animal; Drug Discovery; Gliosis; Hyperalgesia; Lumbar Vertebrae; Male; Microglia; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Cord | 2012 |
[The incidence of postoperative myocardial infarction and the left ventricular function in patients with type 2 diabetes mellitus after recanalization of chronic coronary occlusions].
Topics: Adenosine; Chronic Disease; Comorbidity; Coronary Occlusion; Diabetes Mellitus, Type 2; Humans; Incidence; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Vasodilator Agents; Ventricular Function, Left | 2012 |
Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions.
Topics: Adenosine; Analysis of Variance; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Blood Pressure; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Disease; Female; Humans; Male; Middle Aged; Observer Variation; Ultrasonics; Ultrasonography, Interventional; Vascular Patency; Vascular Resistance | 2003 |
Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Cholinergic Agonists; Chronic Disease; Electric Stimulation; Enteric Nervous System; Ileitis; Ileum; In Vitro Techniques; Isometric Contraction; Male; Mice; Muscle, Smooth; Schistosomiasis mansoni | 2003 |
Polyserositis induced by psicofuranine in man and comparative toxicity in the rat, mouse, chicken, and monkey.
Topics: Adenosine; Animals; Chickens; Chronic Disease; Haplorhini; Humans; Inflammation; Male; Meat; Mice; Rats; Serositis | 1963 |
Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats.
Topics: Adenosine; Animals; Chronic Disease; Hyperalgesia; Male; Pain Measurement; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Stress, Physiological; Xanthines | 2003 |
Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
Topics: Acetylcholine; Acute Disease; Adenosine; Animals; Biological Factors; Chronic Disease; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Hyperhomocysteinemia; Indomethacin; Methionine; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroso Compounds; Oxidation-Reduction; Pinacidil; Potassium Channels; Rats; Rats, Wistar; Renal Circulation; Vasodilation; Vitamin B Complex; Vitamin B Deficiency | 2004 |
Adenosine bronchial provocation with computerized wheeze detection in young infants with prolonged cough: correlation with long-term follow-up.
Topics: Acoustics; Adenosine; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chronic Disease; Cough; Female; Follow-Up Studies; Humans; Infant; Male; Respiratory Sounds | 2004 |
Adenosine-induced long-standing postischemic left ventricular dysfunction evaluated with gated SPECT.
Topics: Adenosine; Chronic Disease; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Ischemia; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice.
Topics: Adenosine; Adenosine Deaminase; Animals; Chronic Disease; Collagen; Disease Models, Animal; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Inflammation Mediators; Lung; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Receptors, Purinergic P1 | 2005 |
Hyperalgesia induced by REM sleep loss: a phenomenon in search of a mechanism.
Topics: Acetylcholine; Adenosine; Anxiety; Chronic Disease; Depression; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; gamma-Aminobutyric Acid; Humans; Hyperalgesia; Nociceptors; Polysomnography; Pons; Prevalence; Reticular Formation; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep, REM | 2006 |
Functional assessment of the collateral-dependent circulation in chronic total coronary occlusion using transthoracic Doppler ultrasound and venous adenosine infusion.
Topics: Adenosine; Adult; Aged; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Echocardiography, Doppler; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Severity of Illness Index; Vasodilator Agents | 2006 |
The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction.
Topics: Adenosine; Aged; Blood Flow Velocity; Blood Pressure; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Disease; Echocardiography, Doppler; Female; Humans; Male; Myocardial Infarction; Myocardial Revascularization; Stress, Physiological; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Caffeine; Cell Differentiation; Cell Lineage; Chronic Disease; Disease Models, Animal; Female; Humans; Hypoxia, Brain; Infant, Newborn; Leukomalacia, Periventricular; Mice; Mice, Inbred C57BL; Nerve Fibers, Myelinated; Neuroprotective Agents; Oligodendroglia; Pregnancy; Receptor, Adenosine A1; Stem Cells | 2006 |
Catabolism of adenine nucleotides favors adenosine production following exercise in patients with chronic heart failure.
Topics: Adenine Nucleotides; Adenosine; Aged; Ammonia; Blood Pressure; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Exercise; Female; Heart; Heart Rate; Humans; Hypoxanthine; Lung; Male; Middle Aged; Oxygen Consumption | 2006 |
Adenosine receptors: novel targets for drug development in allergic rhinitis.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Asthma; Chronic Disease; Humans; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Rhinitis; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Signal Transduction | 2007 |
Reentry and atrial fibrillation.
Topics: Action Potentials; Adenosine; Atrial Fibrillation; Chronic Disease; Heart Atria; Heart Conduction System; Humans; Pulmonary Veins; Tachycardia, Paroxysmal | 2007 |
Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells.
Topics: Adenosine; Animals; Cell Movement; Chronic Disease; Endothelial Cells; Hyperuricemia; Inosine; Ischemia; Ischemic Preconditioning; Kidney; Mice; Mice, Inbred Strains; Oxonic Acid; Stem Cells; Urate Oxidase; Uric Acid | 2007 |
Adenosine and cardioprotection in chronic heart failure: genes and protein expression.
Topics: Adenosine; Adult; Aged; Chronic Disease; Female; Gene Expression; Heart Failure; Humans; Male; Middle Aged; Myocardium; Receptors, Purinergic P1 | 2007 |
Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
Topics: Adenosine; Adult; Aged; Chronic Disease; Dipyridamole; Female; Gene Expression; Gene Expression Profiling; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oligonucleotide Array Sequence Analysis; Phosphodiesterase Inhibitors; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
[Ercevit Fort and chronic venous insufficiency. Application to the treatment of hemorrhoid pathology].
Topics: Adenosine; Alkanesulfonates; Ascorbic Acid; Cardiovascular Agents; Chronic Disease; Drug Combinations; Hemorrhoids; Humans; Rutin; Venous Insufficiency | 1980 |
Characterization of adenosine receptor-mediated generation of cyclic AMP in slices of rat cerebral cortex with chronic epileptic activity.
Topics: 2-Chloroadenosine; Adenosine; Animals; Cerebral Cortex; Chronic Disease; Cyclic AMP; Electroencephalography; Epilepsy; Ferrous Compounds; In Vitro Techniques; Male; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic P1 | 1993 |
Plasma adenosine levels increase in patients with chronic heart failure.
Topics: Adenosine; Adult; Aged; Cardiac Output, Low; Chronic Disease; Female; Humans; Male; Middle Aged; Norepinephrine; Stroke Volume | 1997 |
Myocardial blood flow in awake dogs with chronic tricuspid regurgitation.
Topics: Adenosine; Animals; Cardiac Catheterization; Cardiomegaly; Chronic Disease; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Heart Atria; Heart Ventricles; Organ Size; Physical Exertion; Regional Blood Flow; Rest; Tricuspid Valve Insufficiency; Vascular Resistance; Vasodilator Agents | 1998 |
Acute hemodynamic effects of endogenous adenosine in patients with chronic heart failure.
Topics: Adenosine; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Dipyridamole; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Renal circulatory effects of adenosine in patients with chronic heart failure.
Topics: Adenosine; Adult; Blood Flow Velocity; Chronic Disease; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Renal Circulation; Vascular Resistance; Ventricular Dysfunction, Left | 1998 |
An increase in [3H] CGS21680 binding in the striatum of postmortem brains of chronic schizophrenics.
Topics: Adenosine; Adult; Aged; Antihypertensive Agents; Brain Chemistry; Chronic Disease; Corpus Striatum; Female; Humans; Male; Middle Aged; Phenethylamines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Schizophrenia; Tritium | 1998 |
Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain.
Topics: Adenosine; Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Drug Tolerance; Female; Injections, Spinal; Morphine; Pain; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 1998 |
Effects of chronic unilateral internal pudendal arterial occlusion on reactivity of isolated corpus cavernosum strips from rabbits.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Arteries; Carbachol; Chronic Disease; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Nitroprusside; Papaverine; Parasympathomimetics; Penis; Phenylephrine; Potassium Chloride; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension.
Topics: Acute Disease; Adenosine; Administration, Inhalation; Animals; Chronic Disease; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Injections, Intravenous; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1999 |
Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers.
Topics: Adaptation, Physiological; Adenosine; Animals; Chronic Disease; Ischemia; Ischemic Preconditioning; Kinetics; Liver; Liver Circulation; Male; Protein Isoforms; Rats; Rats, Inbred Lew; Receptors, Purinergic P1; Reperfusion Injury | 1999 |
Measurement of adenylate cyclase activity in the right ventricular endomyocardial biopsy samples from patients with chronic congestive heart failure.
Topics: Adenosine; Adenylyl Cyclases; Adult; Biopsy; Cell Membrane; Chronic Disease; Colforsin; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Norepinephrine; Spectrometry, Fluorescence | 2000 |
Exercise training restores adenosine-induced relaxation in coronary arteries distal to chronic occlusion.
Topics: Adenosine; Animals; Arteries; Calcium; Chronic Disease; Colforsin; Coronary Disease; Coronary Vessels; Female; In Vitro Techniques; Isoproterenol; Nitroprusside; Osmolar Concentration; Physical Conditioning, Animal; Swine; Swine, Miniature; Vasodilation; Vasodilator Agents | 2000 |
Microvascular flow and tissue PO(2) in skeletal muscle of chronic reduced renal mass hypertensive rats.
Topics: Adenosine; Animals; Arterioles; Blood Flow Velocity; Blood Pressure; Capillaries; Chronic Disease; Hematocrit; Hypertension, Renal; Male; Muscle, Skeletal; Oxygen; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Vascular Patency | 2000 |
Hibernating myocardium, stunning, ischemic preconditioning: clinical relevance.
Topics: Adenosine; Angina, Unstable; Angioplasty, Balloon, Coronary; Chronic Disease; Female; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Infarction; Myocardial Stunning; Vasodilator Agents | 2000 |
Reactivity and site of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Almitrine; Angiotensin I; Animals; Bradykinin; Chronic Disease; Hypoxia; Male; Platelet Activating Factor; Pulmonary Circulation; Pyrazines; Rats; Rats, Inbred Strains; Reference Values; Respiration; Vasoconstriction; Vasodilator Agents; Vasomotor System | 1989 |
[Capnography-controlled adenosine loading in chronic respiratory tract diseases in childhood].
Topics: Adenosine; Aerosols; Asthma; Carbon Dioxide; Child; Chronic Disease; Female; Humans; Immunoglobulin E; Lung Diseases, Obstructive; Male; Respiratory Function Tests; Rhinitis, Allergic, Perennial | 1988 |
[Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
Topics: Adenosine; Aged; Calcium Channel Blockers; Chronic Disease; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Fendiline; Humans; Inosine; Male; Middle Aged | 1988 |
Effects of chronic hypertension on vasa vasorum in the thoracic aorta.
Topics: Adenosine; Animals; Aorta, Thoracic; Chronic Disease; Disease Models, Animal; Dogs; Hypertension; Regional Blood Flow; Vasa Vasorum; Vasodilation | 1985 |
[Serum adenosine deaminase in acute viral hepatitis and chronic liver diseases].
Topics: Adenosine; Alanine Transaminase; Alkaline Phosphatase; Aminohydrolases; Aspartate Aminotransferases; Blood Donors; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Fatty Liver; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases | 1973 |
[Serum adenosine desaminase in liver diseases].
Topics: Adenosine; Aminohydrolases; Cholangitis; Cholecystitis; Cholelithiasis; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Fatty Liver; Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Neoplasms | 1973 |
[Various effects of SAM dependent transmethylations in hepatology].
Topics: Adenosine; Biopsy; Chronic Disease; Fatty Liver; Hepatitis; Humans; Injections, Intraperitoneal; Lipid Metabolism; Liver Cirrhosis; Liver Diseases; Liver Glycogen; Methionine; Methylation; S-Adenosylmethionine | 1972 |
[Treatment of glomerulonephritis with metrifudil. Preliminary report].
Topics: Adenosine; Adrenal Cortex Hormones; Azathioprine; Benzyl Compounds; Chronic Disease; Female; Glomerulonephritis; Humans; Male; Prognosis; Proteinuria | 1972 |